Endo International plc - Ordinary Shares (ENDP): Price and Financial Metrics
Endo International plc - Ordinary Shares (ENDP)
Today's Latest Price: $3.18 USD
Updated Apr 3 12:00am
Add ENDP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ENDP Stock Summary
- Endo International plc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 3.43% of US listed stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -14.96 for Endo International plc; that's greater than it is for merely 1.45% of US stocks.
- Over the past twelve months, ENDP has reported earnings growth of -127.07%, putting it ahead of only 11.62% of US stocks in our set.
- Stocks that are quantitatively similar to ENDP, based on their financial statements, market capitalization, and price volatility, are SGMS, ENT, VVUS, SIX, and INAP.
- ENDP's SEC filings can be seen here. And to visit Endo International plc's official web site, go to www.endo.com.
ENDP Stock Price Chart More Charts
ENDP Price/Volume Stats
| Current price | $3.18 | 52-week high | $8.55 |
| Prev. close | $3.09 | 52-week low | $1.97 |
| Day low | $3.01 | Volume | 3,330,100 |
| Day high | $3.25 | Avg. volume | 7,075,272 |
| 50-day MA | $4.88 | Dividend yield | N/A |
| 200-day MA | $4.21 | Market Cap | 721.33M |
Endo International plc - Ordinary Shares (ENDP) Company Bio
Endo International plc focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The company was founded in 1920 and is based in Dublin, Ireland.
ENDP Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $3.18 | $0.39 | -87% |
We started the process of determining a valid price forecast for Endo International plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Endo International plc ranked in the 11th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 87.17%. As for the metrics that stood out in our discounted cash flow analysis of Endo International plc, consider:
- 8% of the company's capital comes from equity, which is greater than just 4.14% of stocks in our cash flow based forecasting set.
- Endo International plc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 0.24. This coverage rate is greater than that of just 19.48% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- The weighted average cost of capital for the company is 17. This value is greater than 98.58% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -88% |
| 1% | -87% |
| 2% | -87% |
| 3% | -87% |
| 4% | -87% |
| 5% | -87% |
CPIX, CPHI, CMD, OSMT, and CRY can be thought of as valuation peers to ENDP, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...